is retatrutide a glp 1 drug Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, CBS News investigation What Is Retatrutide? Dr. Dubrow

Multiple sclerosis patients have peripheral blood CD45RO + B cells and increased intestinal permeability

There are no other absolute contraindications reported for hydroxocobalamin use in deficiency states, but caution is advised in individuals with conditions such as early Lebers optic neuropathy (a rare hereditary optic atrophy) due to the theoretical risk of worsening vision

Temporarily discontinuing self-initiated supplements whilst awaiting medical review is reasonable if symptoms are troublesome, particularly if you began supplementation without confirmed deficiency

Moreover, 18.9% of patients in the GLP1-RAs group required a repeat colonoscopy due to poor bowel preparation, compared to 11.1% of the controls ( p -value 0.041) [28]